Recently, the median survival of patients with AIDS-related lymphoma has changed significantly. This effect is mainly because of changes in the use of antiviral (highly active antiretroviral therapy; HAART) or chemotherapy regimens. Several novel treatment options have been explored in patients with lymphoma. It is hoped that innovative strategies will lead to a survival benefit in these patients. In this review, we present an update of current strategies for the treatment of AIDS-related lymphoma.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1517/14656566.4.8.1331 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!